Skip to content
← Back to this collection

PUBLICATIONS · 32877599

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2020 Sep 17
First author
Dummer R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Dummer R
      type
      Author
    2. name
      Hauschild A
      type
      Author
    3. name
      Santinami M
      type
      Author
    4. name
      Atkinson V
      type
      Author
    5. name
      Mandalà M
      type
      Author
    6. name
      Kirkwood JM
      type
      Author
    7. name
      Chiarion Sileni V
      type
      Author
    8. name
      Larkin J
      type
      Author
    9. name
      Nyakas M
      type
      Author
    10. name
      Dutriaux C
      type
      Author
    11. name
      Haydon A
      type
      Author
    12. name
      Robert C
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Dummer R
      type
      Author
    2. name
      Hauschild A
      type
      Author
    3. name
      Santinami M
      type
      Author
    4. name
      Atkinson V
      type
      Author
    5. name
      Mandalà M
      type
      Author
    6. name
      Kirkwood JM
      type
      Author
    7. name
      Chiarion Sileni V
      type
      Author
    8. name
      Larkin J
      type
      Author
    9. name
      Nyakas M
      type
      Author
    10. name
      Dutriaux C
      type
      Author
    11. name
      Haydon A
      type
      Author
    12. name
      Robert C
      type
      Author
    bibliography ids
    1. nci-bib-6130298f55252b2c21ef455a
    book metadata
    content sha256
    b481ebbe2ebbcd9aef34af6149cf8c0bef9aed61a970f3cda86c43d6ee5b506d
    document type
    citation
    dois
    1. 10.1056/NEJMoa2005493
    electronic publication date
    display
    2020 Sep 2
    precision
    day
    year
    2020
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:32877599
    immutable id
    pubmed:32877599@b481ebbe2ebbcd9aef34af6149cf8c0bef9aed61a970f3cda86c43d6ee5b506d
    journal
    abbreviation
    N Engl J Med
    issn electronic
    1533-4406
    issn print
    0028-4793
    issue
    12
    name
    The New England journal of medicine
    nlm unique id
    0255562
    pages
    1139-1148
    volume
    383
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      32877599
      provenance
      batch id
      9bca82d1bba2b27adc79
      provider
      NCBI PubMed ESummary
      record sha256
      c274dbbdc1cb04cc6a82ecc90b890a666519539b46e0cb1af232ec3ed67778f3
      response sha256
      c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
      retrieved at
      2026-09-09T23:47:56.131551+00:00
      publication date
      display
      2020 Sep 17
      precision
      day
      year
      2020
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/32877599/
      title
      Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.

      Preserved source evidence · Not medical advice